AVITA Medical, Inc. (RCEL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Trans

VALENCIA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a

Avita Medical (RCEL) might move higher on growing optimism about its earnings prospects, which is re

Does Avita Medical Inc. (RCEL) have what it takes to be a top stock pick for momentum investors? Let

AVITA Medical's reimbursement is now becoming more predictable. I believe this removes one of their

TD Cowen analyst Joshua Jennings maintains AVITA Medical (NASDAQ:RCEL) with a Buy and raises the

BTIG analyst Ryan Zimmerman maintains AVITA Medical (NASDAQ:RCEL) with a Buy and raises the price

Avita Medical NASDAQ: RCEL presented results from its PermeaDerm-I study, a randomized controlled tr

AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Transcript

Primary endpoint achieved, demonstrating a 70% economic advantage over allograft based on product co

AVITA Medical's PermeaDerm study shows 70% lower product cost than allograft, with comparable clinic

Avita Medical NASDAQ: RCEL reported second-quarter 2026 revenue of $21.7 million, up 13% sequentiall

Avita Medical NASDAQ: RCEL expects continued sequential revenue growth and aims to reach cash flow b

AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Transcript

VALENCIA, Calif., Aug. 09, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a

Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session.

VALENCIA, Calif., Aug. 07, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a

Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The

Wall Street analysts upgraded AVITA, Etsy, Unity, and raised target prices for these stocks. See wha

BTIG analyst Ryan Zimmerman upgrades AVITA Medical (NASDAQ:RCEL) from Neutral to Buy and announce

Avita Medical NASDAQ: RCEL reported second-quarter 2026 revenue of $21.7 million, up 18% from a year

AVITA Medical, Inc. (RCEL) Q2 2026 Earnings Call Transcript

Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market

AVITA Medical (NASDAQ:RCEL) raises FY2026 sales outlook from $80.000 million-$85.000 million to $86.

AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.25) per share which beat the analyst co

VALENCIA, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a

Celestica Inc (NYSE: CLS) exceeded analyst estimates with quarterly earnings of $2.54 per share and

ServiceNow Inc (NOW) rose in pre-market trading after reporting better-than-expected Q2 results. LGC

VALENCIA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“A

Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's afte

Avita Medical (RCEL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about t

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surge

AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Prepared Remarks Transcript

Lake Street analyst Frank Takkinen upgrades AVITA Medical (NASDAQ:RCEL) from Hold to Buy and rais

AVITA Medical (NASDAQ:RCEL) affirms FY2026 sales outlook from $80.000 million-$85.000 million to $80

AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.35) per share which missed the analyst

AVITA Medical®, Inc. (NASDAQ:RCEL, ASX: AVH)), a leading therapeutic acute wound care company, today

AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today

Agreement ensures rapid nationwide access to RECELL® for burn mass casualty incidents, providing BAR

Northland Capital Markets analyst Carl Byrnes initiates coverage on AVITA Medical (NASDAQ:RCEL) w

D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:RCEL) with a Buy and maint

AVITA Medical (NASDAQ:RCEL) affirms FY2026 sales outlook from $80.000 million-$85.000 million to $80

AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.38) per share which missed the analyst

D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:RCEL) with a Buy and maint